Evidence map›Paper›PMID 33679647›Full record

ArticleFrontiers in microbiology2021

Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions.

Eunji Kim, Young Eun Du, Yeon Hee Ban, Yern-Hyerk Shin, Dong-Chan Oh, Yeo Joon Yoon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eunji KimNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.
Young Eun DuNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.
Yeon Hee BanNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.
Yern-Hyerk ShinNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.
Dong-Chan OhNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.
Yeo Joon YoonNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.
Seoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ohmyungsamycins (OMSs) A and B are cyclic depsipeptides produced by marine

Indexed as

adenylation domain engineeringculture condition optimizationnon-ribosomal peptide synthetaseohmyungsamycinsite-directed mutagenesis

Identifiers

PMID33679647
PMCPMC7925391
OpenAlexW3129842789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.